Clinical Trial Results:
Estudio multicéntrico de búsqueda de dosis, randomizado, doble ciego, controlado con placebo, con grupos de tratamiento paralelos, de RO5313534 administrado como tratamiento adyuvante a donepezilo en pacientes con síntomas de enfermedad de Alzheimer leves a moderados.
A dose ranging, randomized, double blind, parallel-group placebo-controlled multi-center study of RO5313534 used as add-on to donepezil treatment in patients with mild to moderate symptoms of Alzheimer's Disease
Summary
|
|
EudraCT number |
2008-004012-13 |
Trial protocol |
ES FR SK IT DE GB |
Global completion date |
19 Nov 2010
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
08 Jul 2016
|
First version publication date |
12 Jun 2015
|
Other versions |
|
Summary report(s) |
WN22018_CSR synopsis |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.